Skip to main content
. 2022 Jan 11;11:757073. doi: 10.3389/fonc.2021.757073

Figure 1.

Figure 1

Mean values of the systemic levels of examined immunoresolvents in patients with pancreatic cancer and control individuals together with their statistical comparison (values presented as means ± standard deviation in pg/mL). *p < 0.00001 (vs “control” group).